MINNEAPOLIS--(BUSINESS WIRE)--April 26, 2006--"We commend the Heart Rhythm Society (HRS) for its important work in drafting recommendations to improve current reporting practices on pacemakers and implantable cardioverter-defibrillators (ICDs). While we have not had the opportunity to review the proposals in detail, we look forward to working closely with HRS, individual physicians and FDA to continue to enhance patient care.
